Skip to main navigation
 homepage
  • About
  • Science
    • How It Works
    • Our Pipeline
    • Publications
  • Patients
    • Our Commitment To Patients
    • Generalized Myasthenia Gravis
    • Sjögren’s Disease (SD)
  • Careers
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Analyst Coverage
    • Corporate Governance
    • SEC Filings
    • Stock Quote & Chart
    • Contact IR
    • Email Alerts
    • Tax Information
  • Contact

Events & Presentations

Investor Presentations

Vor Bio Corporate Presentation September 2026

Upcoming Events

Morgan Stanley 24th Annual Global Healthcare Conference
Sep 14, 2026
Add to Outlook
Add to Google Calendar
Baird’s 2026 Global Healthcare Conference
Sep 15, 2026 9:05 AM EDT
Add to Outlook
Add to Google Calendar
Stifel’s 2026 Virtual Immunology and Inflammation Forum
Sep 23, 2026 11:30 AM EDT
Click Here for Webcast
Add to Outlook
Add to Google Calendar

Archived Events

Citi’s 2026 Biopharma Back to School Conference
Sep 9, 2026 11:20 AM EDT
Click Here for Webcast
Wells Fargo 21st Annual Healthcare Conference
Sep 8, 2026 8:00 AM EDT
Click Here for Webcast
Vor Bio homepage
  • About
  • Science
    • How It Works
    • Our Pipeline
    • Publications
  • Patients
    • Our Commitment To Patients
    • Myasthenia Gravis
    • Sjögren’s Disease (SD)
  • Careers
  • Investors
    • News Releases
    • Events & Presentations
    • Analyst Coverage
    • Corporate Governance
    • SEC Filings
    • Tax Information
    • Stock Quote & Chart
    • Contact IR
    • Email Alerts
  • Contact

© 2026 Vor Bio | Telitacicept is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).

  • Privacy Policy
  • Terms of Use